期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
植物医药基因工程研究进展
1
作者 谭萍 《生命科学研究》 CAS CSCD 2003年第S1期58-61,共4页
从抗体及动物疫苗在转基因植物中的表达,阐述了植物医药基因工程的进展及意义.植物抗体的表达,在研究植物的代谢和发育、抗病植株的获取以及规模化生产抗体等方面有着广泛的用途.动物疫苗在植物中的表达,简化了疫苗的生产过程,并能使人... 从抗体及动物疫苗在转基因植物中的表达,阐述了植物医药基因工程的进展及意义.植物抗体的表达,在研究植物的代谢和发育、抗病植株的获取以及规模化生产抗体等方面有着广泛的用途.动物疫苗在植物中的表达,简化了疫苗的生产过程,并能使人体获得持久性的疾病防御能力. 展开更多
关键词 植物医药基因工程 药用多肽 疫苗
下载PDF
魅力无穷的基因医学
2
作者 钱红玲 《中国第三产业》 1999年第12期20-20,7,共2页
关键词 基因技术 基因医药 医药市场
下载PDF
Effects of Wei Chang An on expression of multiple genes in human gastric cancer grafted onto nude mice 被引量:12
3
作者 Ai-Guang Zhao Ting Li Sheng-Fu You Hai-Lei Zhao Ying Gu Lai-Di Tang Jin-Kun Yang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第5期693-700,共8页
AIM: To investigate the expression of multiple genes in Chinese jianpi herbal recipe Wei Chang An (WCA) in human gastric cancer cell line SGC-7901. METHODS: A human gastric adenocarcinoma cell line SGC-7902 grafte... AIM: To investigate the expression of multiple genes in Chinese jianpi herbal recipe Wei Chang An (WCA) in human gastric cancer cell line SGC-7901. METHODS: A human gastric adenocarcinoma cell line SGC-7902 grafted onto nude mice was used as the animal model. The mice were randomly divided into 3 groups, one control and the two representing experimental conditions. Animals in the two experimental groups received either WCA over a 34-d period or 5-fluorouracil (5-FU) over 6-d period starting at 8th d after grafting. Control animals received saline on an identical schedule. Animals were killed 41 d after being grafted. The expression profiles in paired WCA treated gastric cancer samples and the N.S. control samples were studied by using a cDNA array representing 14181 cDNA clusters. The alterations in gene expression levels were confirmed by Real-time Quantitative polymerase chain reaction (qPCR). RESULTS: When compared with controls, the average tumor inhibitory rate in WCA group was 44.32% ± 5.67% and 5-FU 47.04% ± 22.33% (P 〈 0.01, respectively). The average labeling index (LI) for PCNA in WCA group and 5-FU group was significantly decreased compared with the control group. Apoptotic index (AI) was significantly increased to 9.72% ± 4.52% using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate fluorescence nick end labeling (TUNEL) method in WCA group compared with the controls 2.45% ± 2.37%. 5-FU group was also found to have a significantly increased AI compared with the controls. The expression of cleaved Caspase-3 in WCA group and 5-FU group was significantly increased compared with the control group respectively. There were 45 different expressed sequence tags (ESTs) among the control sample pool and WCA sample pool. There were 24 ESTs up-regulated in WCA samples and 21 ESTs down-regulated. By using qPCR, the expression level of Stat3, rap2 interacting protein x (RIPX), regulator of differentiation 1 (ROD1) and Bcl-2 was lower in WCA group than that in control group respectively. By using SP immunohistochemical method the expression of Phospho-Stat3 (Tyr705) and Bcl-2 in WCA group and 5-FU group was significantly decreased compared with the control group respectively. CONCLUSION: WCA could inhibit gastric cancer cell SGC-7901 growth in vivo. WCA could induce gastric cancer cell apoptosis and suppress proliferation. Its mechanisms might be involved in the down-regulation of Star3, RIPX, ROD1 and Bcl-2 gene. 展开更多
关键词 Gastric cancer Chinese Jianpi herbs Expressions of multiple genes Real-time quantitative PCR
下载PDF
Preliminary Investigation on Regulating Effects of Different TCM Treatments on Transcription of the Correlated Genes of Liver Cancer in Rats 被引量:6
4
作者 管冬元 方肇勤 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2003年第1期62-66,共5页
The regulating effects of TCM treatments including clearing away heat and toxic materials,promoting blood circulation and removing blood stasis,and strengthening the spleen and regulating qi on the oncogene transcript... The regulating effects of TCM treatments including clearing away heat and toxic materials,promoting blood circulation and removing blood stasis,and strengthening the spleen and regulating qi on the oncogene transcription were observed in the liver cancer model rats.The preliminary results indicated that the mRNA levels of H-ras N-ras and K-ras,and signal molecules correlated with the ras/MAPK signal transduction pathway were down-regulated by the different TCM treatments in varying degrees.Also,the regulating effects of the treatments on differently-displayed genes were discrepant.It is suggested that the molecular mechanisms of the TCM treatments for liver cancer was complex with different target genes. 展开更多
关键词 Animals DIETHYLNITROSAMINE Drugs Chinese Herbal Genes ras Liver Neoplasms Experimental Male Mitogen-Activated Protein Kinase Kinases Protein-Serine-Threonine Kinases RNA Messenger RATS Rats Wistar Signal Transduction Transcription Genetic ras Proteins
下载PDF
Regulative Actions of the Chinese Drugs for Tonifying the Kidney on Gene Expression of the Hypothalamic GnRH,Pituitary FSH,LH and Osteoblastic BGP 被引量:3
5
作者 蔡德培 张炜 王友京 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2005年第1期58-61, ,共4页
It is found that the drugs for nourishing yin to reduce pathogenic fire can significantly down-regulate,and the drugs for tonifying the kidney to replenish essence can up-regulate mRNA expression of the hypothalamic G... It is found that the drugs for nourishing yin to reduce pathogenic fire can significantly down-regulate,and the drugs for tonifying the kidney to replenish essence can up-regulate mRNA expression of the hypothalamic GnRH,pituitary FSH,LH and osteoblastic BGP,indicating that the Chinese drugs for tonifying the kidney can regulate gene expression of the hypothalamic GnRH,pituitary FSH,LH,and osteoblastic BGP,which is possibly one of the main mechanisms of the Chinese drug for tonifying the kidney,regulating ephebic development process and improving skeletal development in sexual precocity children. 展开更多
关键词 Animals Drugs Chinese Herbal Female Follicle Stimulating Hormone GONADORELIN Hypothalamo-Hypophyseal System Luteinizing Hormone Osteoblasts Pituitary Hormone-Releasing Hormones Proteins Puberty Precocious RNA Messenger RATS Rats Sprague-Dawley Yin Deficiency
下载PDF
我国人类基因组研究和医药化工基因产品开发概况
6
作者 齐继成 《中国制药信息》 2000年第6期7-10,共4页
关键词 中国 人类基因 医药化工基因产品 开发
原文传递
中医药系统生物学发展及展望 被引量:38
7
作者 罗国安 梁琼麟 +2 位作者 王义明 刘清飞 李雪 《中国天然药物》 SCIE CAS CSCD 北大核心 2009年第4期242-248,共7页
中医药现代化对中医药研究方法学创新提出了迫切的需求,发展中医药系统生物学成为中医药学和系统生物学的共同要求。本文提出和探讨了中医药整体系统生物学研究的基本策略,拟解决的关键科学问题,主要发展方向及其技术支撑平台,以便推动... 中医药现代化对中医药研究方法学创新提出了迫切的需求,发展中医药系统生物学成为中医药学和系统生物学的共同要求。本文提出和探讨了中医药整体系统生物学研究的基本策略,拟解决的关键科学问题,主要发展方向及其技术支撑平台,以便推动中医药系统生物学快速发展。 展开更多
关键词 医药 医药整体系统生物学 系统-系统 整体表征与局部特征结合 中药化学物质组学 医药基因组学 医药蛋白质组学 医药代谢组学 医药生物信息学
原文传递
Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine 被引量:7
8
作者 HONG HuiXiao ZHANG WenQian +6 位作者 SHEN Jie SU ZhenQiang NING BaiTang HAN Tao PERKINS Roger SHI LeMing TONG WeiDa 《Science China(Life Sciences)》 SCIE CAS 2013年第2期110-118,共9页
Realizing personalized medicine requires integrating diverse data types with bioinformatics.The most vital data are genomic information for individuals that are from advanced next-generation sequencing(NGS) technologi... Realizing personalized medicine requires integrating diverse data types with bioinformatics.The most vital data are genomic information for individuals that are from advanced next-generation sequencing(NGS) technologies at present.The technologies continue to advance in terms of both decreasing cost and sequencing speed with concomitant increase in the amount and complexity of the data.The prodigious data together with the requisite computational pipelines for data analysis and interpretation are stressors to IT infrastructure and the scientists conducting the work alike.Bioinformatics is increasingly becoming the rate-limiting step with numerous challenges to be overcome for translating NGS data for personalized medicine.We review some key bioinformatics tasks,issues,and challenges in contexts of IT requirements,data quality,analysis tools and pipelines,and validation of biomarkers. 展开更多
关键词 personalized medicine next-generation sequencing BIOINFORMATICS short reads ALIGNMENT ASSEMBLE data analysis
原文传递
Genentech公布2005年经营与公益计划
9
《生物技术世界》 2005年第06M期90-90,共1页
全球第二大生物制药企业Genentech期望2005年每股收益的增长能超过25%。2005年Genentech公司的几项临床研究有望得出结果,其中包括Avastin用于非小细胞肺癌和转移性乳腺癌一线治疗的Ⅲ期临床研究。今年,计划提交利妥昔单抗Rituxan治... 全球第二大生物制药企业Genentech期望2005年每股收益的增长能超过25%。2005年Genentech公司的几项临床研究有望得出结果,其中包括Avastin用于非小细胞肺癌和转移性乳腺癌一线治疗的Ⅲ期临床研究。今年,计划提交利妥昔单抗Rituxan治疗非霍奇金淋巴瘤的新适应证的上市申请。同时,与Genentech公司联合开发Tarceva的OSI制药公司计划于今年第二季度提交埃罗替尼治疗胰腺癌的上市申请。 展开更多
关键词 生物制药企业 Genentech公司 2005年 “经营与公益计划” 产品开发 生物医药基因资金 美国
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部